Analytical services center for medications development program. September 25, 2019 - march 24, 2021. N01DA-19-8938. Task order 2 - 75N95019F00089.
Ended Awarded Last action
- Contract number
- 75N95019F00089
- Awardee
-
Xenobiotic Laboratories Inc. UEI K254CMCPAFJ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- Analytical Services Center for Medications Development Pre-Solicitation · NIHDA201800009 · Posted Nov 30, 2017
- Analytical Services Center for Medications Development Program Pre-Solicitation · Posted Jun 5, 2018
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Plainsboro Township, NJ 08536, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$214,791 | |
| Change Order | $0 | |
| Original award | $214,791 |
About this award
Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The delivery order, valued at $0.00 with a period of performance from September 25, 2019 through May 23, 2022, was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health. Under the delivery order, Xenobiotic Laboratories Inc.'s Biotesting Division will provide analytical services in support of the National Institute on Drug Abuse's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
Quick answers
Who was awarded contract 75N95019F00089?
75N95019F00089 was awarded to Xenobiotic Laboratories Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 25, 2019.
How much is contract 75N95019F00089 worth?
The government has obligated $0 on 75N95019F00089.
Is contract 75N95019F00089 an order under another contract?
Yes. 75N95019F00089 is a delivery order under 75N95019D00037, an indefinite delivery contract.
Was contract 75N95019F00089 competed?
The extent of competition for 75N95019F00089 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award